Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 22, 2024 07:00 ET | Source: CytoSorbents

FDA Accepts DrugSorb-ATR De Novo Application To Reduce the Severity of CABG-Related Bleeding Due to Ticagrelor and Initiates Substantive Review

FDA Accepts DrugSorb-ATR De Novo Application To Reduce CABG-Related Bleeding Severity Due To Brilinta, Starting Substantive Review, 2025 Decision Expected
January 23, 2024 09:00 ET | Source: Rapsodo

Rapsodo Partners with Titleist to Further Enhance the Premium Member Experience for the Rapsodo MLM2PRO

ST. LOUIS, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Rapsodo, the company known for leading the revolution to affordable, pro-grade sports technology to help athletes play like never before, announces a...
January 17, 2024 07:15 ET | Source: CytoSorbents

Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients

CytoSorb Blood Purification Results in Significant Decrease in Organ Failure and Dysfunction in Groundbreaking Heart Transplant Randomized Controlled Trial
December 28, 2023 07:00 ET | Source: CytoSorbents

CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation

CytoSorbents Provides Update on STAR-T Trial and Final Independent DSMB Recommendation
June 15, 2023 07:00 ET | Source: CytoSorbents

CytoSorbents Announces Independent Data Safety and Monitoring Board Recommends Completion of the Pivotal STAR-T Trial Without Modifications Following Second Scheduled Safety Review

PRINCETON, N.J., June 15, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
July 15, 2020 08:00 ET | Source: Daxor Corporation

Daxor Announces Initiation of First-of-Its-Kind Multicenter BVA-100® Study in Hospitalized Patients With COVID-19

COVID-19 Investigation Commences at NYU Langone Health with Daxor’s Blood Volume Analysis Technology NEW YORK, July 15, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment...
September 28, 2017 13:25 ET | Source: Atari, Inc.

Chris Sawyer and Atari(R) Announce RollerCoaster Tycoon(R) Classic(TM) Now Available on Steam for Windows PC and Mac

NEW YORK, NY--(Marketwired - September 28, 2017) - Chris Sawyer, creator and producer of the RollerCoaster Tycoon® series, and Atari®, one of the world's most recognized publishers and producers of...